Lelieveld Stefan H, Wiel Laurens, Venselaar Hanka, Pfundt Rolph, Vriend Gerrit, Veltman Joris A, Brunner Han G, Vissers Lisenka E L M, Gilissen Christian
Department of Human Genetics, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, 6525 GA, the Netherlands.
Department of Human Genetics, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, 6525 GA, the Netherlands; Centre for Molecular and Biomolecular Informatics, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, 6525 GA, the Netherlands.
Am J Hum Genet. 2017 Sep 7;101(3):478-484. doi: 10.1016/j.ajhg.2017.08.004. Epub 2017 Aug 31.
Haploinsufficiency (HI) is the best characterized mechanism through which dominant mutations exert their effect and cause disease. Non-haploinsufficiency (NHI) mechanisms, such as gain-of-function and dominant-negative mechanisms, are often characterized by the spatial clustering of mutations, thereby affecting only particular regions or base pairs of a gene. Variants leading to haploinsufficency might occasionally cluster as well, for example in critical domains, but such clustering is on the whole less pronounced with mutations often spread throughout the gene. Here we exploit this property and develop a method to specifically identify genes with significant spatial clustering patterns of de novo mutations in large cohorts. We apply our method to a dataset of 4,061 de novo missense mutations from published exome studies of trios with intellectual disability and developmental disorders (ID/DD) and successfully identify 15 genes with clustering mutations, including 12 genes for which mutations are known to cause neurodevelopmental disorders. For 11 out of these 12, NHI mutation mechanisms have been reported. Additionally, we identify three candidate ID/DD-associated genes of which two have an established role in neuronal processes. We further observe a higher intolerance to normal genetic variation of the identified genes compared to known genes for which mutations lead to HI. Finally, 3D modeling of these mutations on their protein structures shows that 81% of the observed mutations are unlikely to affect the overall structural integrity and that they therefore most likely act through a mechanism other than HI.
单倍剂量不足(HI)是显性突变发挥作用并导致疾病的最具特征性的机制。非单倍剂量不足(NHI)机制,如功能获得和显性负性机制,通常以突变的空间聚集为特征,从而仅影响基因的特定区域或碱基对。导致单倍剂量不足的变异偶尔也可能聚集,例如在关键结构域中,但总体而言,这种聚集在突变经常散布于整个基因时不太明显。在这里,我们利用这一特性开发了一种方法,用于在大型队列中特异性识别具有新生突变显著空间聚集模式的基因。我们将我们的方法应用于来自已发表的智力残疾和发育障碍(ID/DD)三联体外显子组研究的4061个新生错义突变数据集,并成功识别出15个具有聚集突变的基因,其中包括12个已知突变会导致神经发育障碍的基因。在这12个基因中的11个中,已报道了NHI突变机制。此外,我们识别出三个与ID/DD相关的候选基因,其中两个在神经元过程中具有既定作用。我们进一步观察到,与已知突变导致HI的基因相比,所识别基因对正常遗传变异的耐受性更高。最后,对这些突变在其蛋白质结构上进行的三维建模表明,81%观察到的突变不太可能影响整体结构完整性,因此它们很可能通过HI以外的机制发挥作用。